Zomedica Corp. Reports Quarterly Results for Quarter Ended June 30, 2026

What Happened

• Zomedica Corp. announced its financial results for the quarter ended June 30, 2026. The company filed a Form 8-K on August 5, 2026 (Item 2.02) and furnished a press release with those results as Exhibit 99.1, which is incorporated by reference into the filing.

Key Details

• Filing date: August 5, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Period covered: quarter ended June 30, 2026.
• Press release containing the results is furnished as Exhibit 99.1 and incorporated by reference.
• The 8-K does not include other material items (no executive changes or corporate transactions were reported in this filing).

Why It Matters

• This filing provides the company’s latest reported quarterly results—material information investors use to evaluate revenue, profitability and financial condition.
• Investors should review the press release (Exhibit 99.1) and any related SEC filings (e.g., quarterly reports) for the specific financial figures and management commentary before making investment decisions.